BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11015376)

  • 1. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.
    Brisse S; Milatovic D; Fluit AC; Kusters K; Toelstra A; Verhoef J; Schmitz FJ
    J Clin Microbiol; 2000 Oct; 38(10):3636-45. PubMed ID: 11015376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.
    Landman D; Quale JM; Mayorga D; Adedeji A; Vangala K; Ravishankar J; Flores C; Brooks S
    Arch Intern Med; 2002 Jul; 162(13):1515-20. PubMed ID: 12090889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCR identification and automated ribotyping of Pseudomonas aeruginosa clinical isolates from intensive care patients.
    Sarwari A; Hasan R; Lim CB; Ng Y; Ng C; Zaman S
    Scand J Infect Dis; 2004; 36(5):342-9. PubMed ID: 15287378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.
    Lee K; Kim MN; Kim JS; Hong HL; Kang JO; Shin JH; Park YJ; Yong D; Jeong SH; Chong Y;
    Yonsei Med J; 2011 Sep; 52(5):793-802. PubMed ID: 21786445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study.
    Vahaboglu H; Oztürk R; Aygün G; Coşkunkan F; Yaman A; Kaygusuz A; Leblebicioglu H; Balik I; Aydin K; Otkun M
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2265-9. PubMed ID: 9333059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.
    Unal S; Garcia-Rodriguez JA
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):265-71. PubMed ID: 16360550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
    Jones RN; Pfaller MA; Marshall SA; Hollis RJ; Wilke WW
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):187-92. PubMed ID: 9401811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003).
    Jones RN; Deshpande L; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):211-6. PubMed ID: 15246512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
    Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
    Mekonnen H; Seid A; Molla Fenta G; Gebrecherkos T
    PLoS One; 2021; 16(11):e0257272. PubMed ID: 34780494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of
    Djordjevic ZM; Folic MM; Jankovic SM
    Balkan Med J; 2017 Dec; 34(6):527-533. PubMed ID: 29215335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species.
    Paterson DL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S43-8. PubMed ID: 16894514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital.
    De Francesco MA; Ravizzola G; Peroni L; Bonfanti C; Manca N
    J Infect Public Health; 2013 Jun; 6(3):179-85. PubMed ID: 23668462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Gales AC; Jones RN; Turnidge J; Rennie R; Ramphal R
    Clin Infect Dis; 2001 May; 32 Suppl 2():S146-55. PubMed ID: 11320454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000.
    Friedland I; Stinson L; Ikaiddi M; Harm S; Woods GL
    Diagn Microbiol Infect Dis; 2003 Apr; 45(4):245-50. PubMed ID: 12729994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].
    Yüce A; Yapar N; Eren Kutsoylu O
    Mikrobiyol Bul; 2009 Apr; 43(2):195-202. PubMed ID: 19621603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.